We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $1.68B
1-Year Est. Return 373.57%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+373.57%
3 Year Est. Return
+2,009.68%
5 Year Est. Return
+1,118.82%
10 Year Est. Return
+17,700.84%
AUM
$496M
AUM Growth
-$106M
Cap. Flow
-$118M
Cap. Flow %
-23.88%
Top 10 Hldgs %
49.17%
Holding
200
New
51
Increased
18
Reduced
16
Closed
65

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.39%
2 Technology 12.96%
3 Consumer Discretionary 11.32%
4 Healthcare 8.06%
5 Real Estate 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACER
176
DELISTED
Acer Therapeutics Inc
ACER
-129,795
Closed -$120K
AAC.WS
177
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
-250,000
Closed -$2.64M
DRCTW
178
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
-804,114
Closed -$2.29M
BTWNW
179
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
-127,634
Closed -$1.31M
SYNH
180
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-55,000
Closed -$2.32M
MBSC.WS
181
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
-133,333
Closed -$1.39M
CBRGW
182
DELISTED
Chain Bridge I Warrants
CBRGW
-50,000
Closed -$526K
SMFL
183
DELISTED
Smart for Life, Inc. Common Stock
SMFL
-9,549
Closed -$463K
ABST
184
PUT
DELISTED
Absolute Software Corp
ABST
-50,000
Closed -$573K
TWCBW
185
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
-43,749
Closed -$444K
VBOCW
186
DELISTED
Viscogliosi Brothers Acquisition Corp Warrant
VBOCW
-24,982
Closed -$263K
ISEE
187
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-122,650
Closed -$4.83M
BIOC
188
DELISTED
Biocept, Inc.
BIOC
-44,861
Closed -$54.3K
BIOR
189
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-61,713
Closed -$2.38M
MBAC.WS
190
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
-589,641
Closed -$6.04M
BOAC.WS
191
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
-358,293
Closed -$3.58M

Similar funds

Anson Funds Management's Q3 2023 Portfolio in Review

As of Q3 2023, Anson Funds Management held 200 positions worth $496M, down 18% from $602M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Anson Funds Management withdrew a net $118M in Q3 2023, closing 65 positions and reducing 16 holdings. Its most notable exit was Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50, an estimated $65.2M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 52% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Anson Funds Management opened a new position in Oncolytics Biotech worth $11.6M.

  • Anson Funds Management's largest Q3 2023 buy was Oncolytics Biotech: 5,302,036 shares worth $11.6M.
  • Anson Funds Management added most to Activision Blizzard in Q3 2023, an estimated $8.21M increase.
  • Anson Funds Management's biggest Q3 2023 reduction was Occidental Petroleum, cutting an estimated $21.4M.
  • Anson Funds Management fully exited Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2023, selling an estimated $65.2M.
  • Anson Funds Management's ten largest holdings make up 49% of its $496M portfolio in Q3 2023.
  • Anson Funds Management opened 51 new positions and closed 65 in Q3 2023.
  • Anson Funds Management's portfolio value fell 18% quarter-over-quarter to $496M.

Based on Anson Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.